Volume 15, Number 12—December 2009
Research
Genomic Signatures of Influenza A Pandemic (H1N1) 2009 Virus
Table 4
Gene | Position | Avian virus residue | Recent swine viruses residue† | Pandemic (H1N1) 2009 virus residue | Human virus residue |
---|---|---|---|---|---|
PB2 |
684 |
A(3,278), T(70), S(11), V(9), G(6), D(1), E(1) |
A(18) |
S(61) |
S(1,944), A(806), G(2), P(2), Y(1) |
PB1 |
216 |
S(3,299), G(62), N(37), C(11), I(7) |
G(9), S(7)‡ |
G(80) |
G(1,708), S(1,039), N(5), I(4), D(1) |
PA | 204 | R(2,202), K(674), E(1), G(1), S(1) | R(17) | K(61) | K(1,776), R(991) |
356 | K(3,309), R(34), N(7), E(1), I(1) | K(16), R(1) | R(61) | R(2,705), K(30) |
*Boldface indicates dominant amino acid residue type. PB, polymerase B; PA, polymerase A.
†Same 18 recent ancestral swine viruses used in Table 3.
‡PB1-216 is dominated by residue G (G[8), S[1]) when considering only a subset of 9 PB1 sequences that are phylogenetically closer to pandemic (H1N1) 2009 virus. This statistic clearly shows the amino acid residue transition from avian to human signature within the population of recent swine viruses.
Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.